Art Vreugdenhil

De Run
Eindhoven, NB, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Herbs, vitamins, and minerals during anticancer treatment

Herbs, vitamins, and minerals during anticancer treatment

Journal: Nederlands tijdschrift voor geneeskunde

Published: August 27, 2026

Death Anxiety During the Last Year of Life in Patients With Advanced Cancer: Longitudinal Results From the eQuiPe Study.

Death Anxiety During the Last Year of Life in Patients With Advanced Cancer: Longitudinal Results From the eQuiPe Study.

Journal: Psycho-oncology

Published: January 30, 2026

Patients' and relatives' perspectives on the quality of end-of-Life care in advanced cancer: From the final months to bereavement.

Patients' and relatives' perspectives on the quality of end-of-Life care in advanced cancer: From the final months to bereavement.

Journal: PloS one

Published: October 06, 2025

Deep learning on CT scans to predict checkpoint inhibitor treatment outcomes in advanced melanoma.

Deep learning on CT scans to predict checkpoint inhibitor treatment outcomes in advanced melanoma.

Journal: Scientific reports

Published: April 02, 2024

CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma.

CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 22, 2022

Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors.

Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors.

Journal: Melanoma research

Published: June 15, 2022

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.

Journal: British journal of cancer

Published: March 08, 2022

Adjuvant treatment for melanoma in clinical practice - Trial versus reality.

Adjuvant treatment for melanoma in clinical practice - Trial versus reality.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 02, 2021

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.

Journal: British journal of cancer

Published: March 16, 2021

Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastases.

Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastases.

Journal: Melanoma research

Published: December 22, 2020

Perceptions of involvement in advance care planning and emotional functioning in patients with advanced cancer.

Perceptions of involvement in advance care planning and emotional functioning in patients with advanced cancer.

Journal: Journal of cancer survivorship : research and practice

Published: October 31, 2020

First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.

First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.

Journal: British journal of cancer

Published: July 02, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026